NGF antagonist and opioid analgesic use in pain treatment
An antagonist, opioid technology, applied in the field of NGF antagonists and opioid agents in the treatment of pain, can solve problems such as limiting clinical use
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0188] Anti-NGF monoclonal antibody combined with opioid analgesics for postoperative pain
[0189] We evaluated the efficacy of an anti-NGF antibody in combination with an opioid analgesic (morphine) using a pain model that mimics postoperative pain. Each experiment included 16 animals (n=8 / group).
[0190] animal. For each experiment, 16 male adult Sprague Dawley rats (Harlan; Indianapolis, IN) weighing 200-220 g were housed under normal light conditions for at least one week prior to use with food and water ad libitum.
[0191] On the day before the operation, after acclimatizing the rats in the experimental cage for 2 hours, the rats were divided into two groups: one group received the antibody 15 hours before the operation, and the other group received the vehicle (5% glucose / 0.45 % saline USP). Anti-NGF antagonist antibody Mab 911 (see Hongo, et al., Hybridoma 19:215-227 (2000)) was administered intraperitoneally (i.p.) at a concentration of 0.3-20 mg / kg. Twenty-four...
PUM
Property | Measurement | Unit |
---|---|---|
affinity | aaaaa | aaaaa |
affinity | aaaaa | aaaaa |
affinity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com